Delinking compensation for
#PBMs and other middlemen from drug prices – and using fair, transparent fees instead – could save about $95B annually, according to an analysis from USC Schaeffer’s Geoffrey Joyce.
Delinking PBM Compensation From Drug List Prices Could Unleash Major Savings - July 24, 2025 - USC Schaeffer
Reforming payments to PBMs and other pharmacy middlemen could lower annual U.S. drug spending by nearly $100 billion without hurting innovation, finds Schaeffer Center research. - July 24, 2025
